Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Ockham Research (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Borders Hopes a Capital Infusion and New Chairman Will Stoke Turnaround

% of readers think this story is Fact. Add your two cents.


On Friday, Borders Group (BGP) announced a private placement with financier Bennett LeBow of $25 million equity stake.  LeBow grabbed 11.1 million shares for $2.25 per share and in one fell swoop became the company’s largest shareholder, pushing aside Bill Ackman’s Pershing Square Capital Management.  The deal is highly dilutive to current shareholders as it grows the current shares outstanding by 19% to 70.9 million in total.  Furthermore, the deal also nets LeBow an additional 35.1 million warrants to buy shares at the $2.25 level pending shareholder approval.

Borders Group intends to use the capital in order to revamp its website and market its new low cost eReader.  We recently wrote about Border’s new eBook strategy (Borders Banking on the Low End of eReader Market), as digital book sales are growing far more rapidly than physical book sales.  Borders is working to cut costs and close stores as the second largest US book retailer has not been profitable for four straight years and sales are more than one-third lower than they were five years ago.  Clearly, a change in strategy is necessary, but Borders long term success appears to rest with the cheap, simple Kobo eReader which will compete directly with Amazon’s (AMZN) Kindle and Apple’s (AAPL) iPad.

LeBow, a long time chairman of tobacco holding company Vector Group, will actively participate in his investment as he will take over chairmanship at Borders Group.  Interestingly, the market has cheered the move as Borders traded as much as 9% higher on Friday despite the massive dilution, however it has come off that level and traded just about even late in the day (still impressive consider 19% more shares outstanding).  It appears the shake-up in management is being seen as a positive at this time, but we have to believe the market will react negatively to the increased share base, especially if the more than 35 million warrants are approved.  After all, coming into the day there were under 60 million shares outstanding.

At Ockham, we are reaffirming our Fairly Valued stance on BGP as of this week’s report.  Of course, we will learn more about the how the company is performing when they report earnings next week, but we are not expecting Borders to show a profitable quarter.  Coming into the day, BGP was trading for just .05x sales per share, which is well below the historically normal price-to-sales valuation range for BGP of 0.17x to 0.33x.  The stock is appealing as far as per share valuations are concerned, but remember the share base grew massively today.  Current shareholders have been greatly diluted, but if they use the capital wisely and pull BGP into the black no one will complain; least of all Mr. LeBow who has the potential to own 46 million shares.

Read the original story at Ockham Research



Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login